In this week's episode, Dr. Goodyear interviews Dr. John Catanzaro, owner and CEO of Neo7Bioscience about the incredible science behind peptides and their use in a variety of treatments, including cancer.
ABOUT DR. JOHN CATANZARO
Dr. John Catanzaro serves as CEO, Founder, Chairman, and Product Development Officer of Neo7Bioscience, a precision/personalized molecular design biotech company.
Dr. Catanzaro received his Doctorate of Naturopathic Medicine (N.M.D.) from Bastyr University in 1995, and his Doctorate of Theology and Ethics (D.T.S; Th.D.) from Bethany Divinity Seminary in 2012.
After 22 years of clinical practice treating patients with cancer and chronic illness, he retired in 2017, where he was the founder and CEO of a cancer institute and research development group of genetic and proteomic technology innovating patient-precision genetically matched immunopeptides.
In addition, Dr. Catanzaro is the coinventor of a precision augmentation platform known as PBIMA. The platform includes multiomic / proteomic sequencing and prediction, CRISPR prime editing features, and proteomics in a 3D integration utilizing unified proprietary mapping informatics and computation, superior ranking, and selection architecture.
Dr. Catanzaro is a thought leader in molecular bioscience and biotechnology and brings forth a wealth of knowledge and his experience to architect precision-based personalized therapeutics in healthcare. Before his career in medicine and biosciences, he was engaged in the aerospace industry in various capacities, including stints for the USAF and The Boeing Company.
To learn more about Dr. Goodyear, visit his website at drgoodyear.com.
For more interesting videos on a variety of topics, TikTok videos are updated daily at www.tiktok.com/@briomedical and long-form videos can be found on our YouTube Channel www.youtube.com/@BrioMedical.
Patients interested in pursuing their cancer healing journey can visit Dr. Goodyear at Brio Medical in Scottsdale, Arizona by visiting brio-medical.com.